# Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy

> **NCT04872218** · PHASE2 · COMPLETED · sponsor: **Philippe Bégin** · enrollment: 14 (actual)

## Conditions studied

- Peanut Allergy

## Interventions

- **DRUG:** Abatacept
- **DRUG:** Placebo
- **OTHER:** Peanut oral immunotherapy

## Key facts

- **NCT ID:** NCT04872218
- **Lead sponsor:** Philippe Bégin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-01
- **Primary completion:** 2024-05-10
- **Final completion:** 2024-11-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04872218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04872218, "Adjuvant Treatment With Abatacept to Promote Remission During Peanut Oral Immunotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04872218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*